Akinetic Crisis in Parkinson’s Disease Following the Withdrawal of Continuous Subcutaneous Foslevodopa-Foscarbidopa Infusion: A Case Report

Akinetic crisis (AC) in Parkinson's disease (PD) is a life-threatening complication precipitated by abrupt changes or the impaired absorption of dopaminergic medication. We report a case of AC precipitated by an unintended suspension of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) in a patient with advanced PD in a perioperative setting. Our observations highlight that despite its reputation as a reliable device-aided therapy (DAT), CSFLI remains vulnerable to abrupt interruptions and it may entail an under-recognized risk of AC. This case underscores the need for alternative dopaminergic routes, careful perioperative planning, and multidisciplinary collaboration in managing patients with advanced PD undergoing DAT.

Authors

Publication Details

Journal
Internal Medicine
Published
2026-11-19
DOI
https://doi.org/10.2169/internalmedicine.7414-26
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Akinetic Crisis in Parkinson’s Disease Following the Withdrawal of Continuous Subcutaneous Foslevodopa-Foscarbidopa Infusion: A Case Report

Hideo Kihara, Yugaku Daté, 笠井陽介, Kiyokazu Kawabe et al.
4 links
Internal Medicine
Parkinson's Disease Mechanisms and Treatments
article

Akinetic Crisis in Parkinson’s Disease Following the Withdrawal of Continuous Subcutaneous Foslevodopa-Foscarbidopa Infusion: A Case Report

Hideo Kihara, Yugaku Daté, 笠井陽介, Kiyokazu Kawabe, Koki Iritani, Akihiro Warabi, Kanon Kobayashi, Tomoki Kamiya
article en

Abstract

Akinetic crisis (AC) in Parkinson's disease (PD) is a life-threatening complication precipitated by abrupt changes or the impaired absorption of dopaminergic medication. We report a case of AC precipitated by an unintended suspension of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) in a patient with advanced PD in a perioperative setting. Our observations highlight that despite its reputation as a reliable device-aided therapy (DAT), CSFLI remains vulnerable to abrupt interruptions and it may entail an under-recognized risk of AC. This case underscores the need for alternative dopaminergic routes, careful perioperative planning, and multidisciplinary collaboration in managing patients with advanced PD undergoing DAT.

Internal Medicine
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon